Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Mayo Clinic, Cancer Genetics form biomarker JV OncoSpire Genomics

Executive Summary

Following two years of discussions, the Mayo Clinic and newly public Cancer Genetics Inc. (DNA-based cancer diagnostics) have formed the joint venture, OncoSpire Genomics, which has been tasked with discovering and commercializing new cancer tests that will utilize next-generation sequencing.
Deal Industry
  • Biotechnology
    • Pharmacogenetics-Pharmacogenomics
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
Deal Status
  • Final
Deal Type
  • Alliance
    • Includes Equity
    • R+D and Marketing-Licensing
    • Joint Venture
UsernamePublicRestriction

Register